Myers Michael
SEC CIK 1959547 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| QNRX | Quoin Pharmaceuticals Ltd. | CEO, Dir | 37.7K | $379.0K | — | 3 | 2024-09-03 | 2026-08-31 |
Most active insiders at QNRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | LANGER DENNIS | Dir | $128.6K | — |
| 2 | Myers Michael | CEO, Dir | $100.0K | — |
| 3 | Carter Denise P. | COO, Dir | $100.0K | — |
| 4 | Lawlor Sally Bridget | CFO | $50.0K | — |
| 5 | Culverwell Anthony James | Dir | $30.0K | — |
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-01 21:39 | 2026-08-31 | QNRX | Quoin Pharmaceuticals Ltd. | Myers Michael | CEO, Dir | P - Purchase | $4.88 | +20.5K | 37.7K | +119% | +$100.0K |
| D | 2024-12-27 | 2024-12-23 | QNRX | Quoin Pharmaceuticals Ltd. | Myers Michael | CEO, Dir | P - Purchase | $0.45 | +555.6K | 602.8K | +1,176% | +$250.0K |
| M | 2024-09-05 | 2024-09-03+ | QNRX | Quoin Pharmaceuticals Ltd. | Myers Michael | CEO, Dir | P - Purchase | $0.7657 | +37.9K | 23.7K | New | +$29.0K |
Purchase Sale Sale after option exercise All abbreviations